Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.630
-0.150 (-5.40%)
Mar 12, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 8.00K | 170.00K | 11.07M | - | - | |
Biotechnology (Startups) Growth | -95.29% | -98.46% | - | - | - | |
| 8.00K | 170.00K | 11.07M | - | - | |
| -95.29% | -98.46% | - | - | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 8.00K | 170.00K | 11.07M | - | - | |
| -95.29% | -98.46% | - | - | - | |
| 8.00K | 170.00K | 11.07M | - | - | |
| -95.29% | -98.46% | - | - | - | |
Source: S&P Global Market Intelligence.
